# FDA Inspection 1197521 - Biomat USA Plasma Center - January 20, 2023

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-plasma-center/bfd6fc4b-5b8b-43f3-a1bb-d8fa2b1e3c0c
Source feed: FDA_Inspections

> FDA Inspection 1197521 for Biomat USA Plasma Center on January 20, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1197521
- Company Name: Biomat USA Plasma Center
- Inspection Date: 2023-01-20
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1197521 - 2023-01-20](https://www.keypedia.com/records/fda_inspections/biomat-usa-plasma-center/6dc9199b-82fd-4f31-9118-42ae99858b84)
- [FDA Inspection 1058461 - 2018-06-06](https://www.keypedia.com/records/fda_inspections/biomat-usa-plasma-center/654aa27c-b91c-451f-86bb-48aa6a71b5b9)
- [FDA Inspection 989198 - 2016-09-27](https://www.keypedia.com/records/fda_inspections/biomat-usa-plasma-center/c3fada8d-861f-453d-9438-01d0a31ef013)

Company: https://www.keypedia.com/companies/biomat-usa-plasma-center/35b6c4ca-c730-4328-8f39-aa80d8061d4f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d